Provider profile
MEDVi — compounded GLP-1 pricing & profile
Captured pricing, fees, pharmacy disclosure, and evidence status — provider-reported, not checkout-verified.
MEDVi is a compounded GLP-1 access channel captured in this site's provider directory. This profile summarizes what is verified about its pricing, fees, pharmacy disclosure, and evidence status as of 2026-07-20 — provider-reported and not checkout-verified — and shows how it sits against the market's lowest rankable captured cost.
Captured pricing
MEDVi does not publish a single flat compounded price in the captured data. Semaglutide: Advertised from $179 for the first month, all-inclusive. Tirzepatide: Exact current tirzepatide price not publicly verified in this capture. Because no stable per-plan figure was captured, MEDVi is shown for transparency but is not placed in the ranked pricing tables. Confirm current pricing on the provider's own page before relying on any figure.
How MEDVi compares
Effective monthly cost folds every mandatory charge into one number. Against the market's lowest rankable captured cost (advertised, not checkout-verified):
| Medication | MEDVi | Lowest rankable | Standing |
|---|---|---|---|
| compounded semaglutide | not captured | $145.00 (NexLife) | no comparable semaglutide figure captured for MEDVi |
| compounded tirzepatide | not captured | $186.00 (NexLife) | no comparable tirzepatide figure captured for MEDVi |
Lowest-rankable is an advertised-price figure, not a verified "cheapest" ranking. Providers with approximate, dose-dependent, or conflicting pricing are excluded from the rankable set — see the pricing pages for exclusions.
Fees, pharmacy, and disclosure
| Category | Compounded-GLP-1-focused |
| Current status | Active but evidence incomplete |
| Membership / program fee | Advertised first-month semaglutide price is bundled |
| Pharmacy disclosure | Not verified |
| Material relationship | No known material relationship — publisher attested 2026-07-20; independent verification not performed |
| Evidence status | PENDING · confidence moderate |
| Last checked | 2026-07-20 |
| Official source | provider page |
Capture note: Recurring price and dose/formulation must be verified before comparison.
How to evaluate MEDVi before paying
Whatever the headline, run the same checks on any compounded provider: (1) compute effective monthly cost at your maintenance dose, membership included; (2) get the renewal price, not just the first month; (3) name and verify the dispensing pharmacy with the four-step workflow; (4) confirm the refund and cancellation terms in writing before any prepaid plan. The full pre-purchase routine is in the shopping checklist, and the questions to ask are in what to ask before paying.
Frequently asked questions
How much does MEDVi charge for compounded GLP-1?
MEDVi did not publish a single flat compounded price in the captured data — advertised from $179 for the first month, all-inclusive. Confirm current pricing directly with the provider, and compute effective monthly cost at your maintenance dose before comparing.
Does MEDVi charge a membership fee?
A membership or program fee was not clearly reported. Captured: Advertised first-month semaglutide price is bundled. A required membership belongs in the effective-cost math, so add it in before comparing MEDVi to any flat-priced provider.
Is MEDVi's pricing verified?
No. MEDVi's evidence status is verification pending (confidence moderate); figures are provider-reported or independently calculated, not checkout-verified, and its pharmacy disclosure is "not verified". Treat every figure as a starting point to confirm, not a guarantee.